Update on clinical significance of coagulase-negative staphylococci

Clinical Microbiology Reviews

Volumn 7, Issue 1, 1994, Pages 117-140

  Kloos, Wesley E ^a   Bannerman, Tammy L ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIOPHAGE TYPING; BACTERIUM IDENTIFICATION; BIOTYPOLOGY; BLOOD CULTURE; CHROMOSOME ANALYSIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; ELECTROPHORESIS; EXUDATE; MASS SPECTROMETRY; MORPHOLOGY; NONHUMAN; PATHOGENESIS; PLASMID; PROSTHESIS; PROTEIN ANALYSIS; REVIEW; SAMPLING; STAPHYLOCOCCUS; STRAIN DIFFERENCE; TISSUE CULTURE; URINE CULTURE;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCI; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0028158773     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.7.1.117     Document Type: Review

References (323)

1. Aldridge, K. E. 1992. In vitro antistaphylococcal activities of two investigative fluoroquinolones, CI-960 and WIN 57273, compared with those of ciprofloxacin, mupirocin (pseudomonic acid), and peptide-class antimicrobial agents. Antimicrob. Agents Chemother. 36:851-853.
2. Allen, R. C., R. L. Stjenholm, and R. H. Steele. 1972. Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem. Biophys. Res. Commun. 47:679-684.
3. Anderson, J. D., A. M. Clarke, M. E. Anderson, J. L. Isaac-Renton, and M. G. McLoughlin. 1981. Urinary tract infections due to Staphylococcus saprophyticus biotype 3. Can. Med. Assoc. J. 124:415-418.
4. Archer, G. L. 1985. Coagulase-negative staphylococci in blood cultures: a clinicians dilemma. Infect. Control 6:477-478.
5. Archer, G. L., and E. Pennell. 1990. Detection of methicillin resistance in staphylococci by using a DNA probe. Antimicrob. Agents Chemother. 34:1720-1724.
6. Archer, G. L., and J. Scott. 1991. Conjugative transfer genes in staphylococcal isolates from the United States. Antimicrob. Agents Chemother. 35:2500-2504.
7. Archer, G. L., G. J. Vazquez, and J. L. Johnson. 1980. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. J. Infect. Dis. 142:725-731.
8. Archer, G. L., N. Vishniavsky, and H. B. Stiver. 1982. Plasmid pattern analysis of staphylococcal epidermidis isolates from patients with prosthetic valve endocarditis. Infect. Immun. 35:627-632.
9. Aries, R. E., C. S. Gutteridge, and T. W. Ottley. 1986. Evaluation of a low-cost, automated pyrolysis-mass spectrometer. J. Anal. Appl. Pyrolysis 9:81-98.
10. Aufwerber, E., S. Ringertz, and U. Ransjö. 1991. Routine semiquantitative cultures and central venous catheter-related bacteremia. Acta Pathol. Microbiol. Immunol. Scand. 99:627-630.
11. Baddour, L. M., T. N. Phillips, and A. L. Bisno. 1986. Coagulase-negative staphylococcal endocarditis: occurrence in patients with mitral valve prolapse. Arch. Intern. Med. 146:119-121.
12. Bailey, E. M., T. D. Constance, L. M. Albrecht, and M. J. Rybak. 1990. Coagulase-negative staphylococci: incidence, pathogenicity, and treatment in the 1990s. DICP Ann. Pharmacother. 24:714-720.
13. Baker, C. N., S. A. Stocker, D. H. Culver, and C. Thornsberry. 1991. Comparison of the E test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J. Clin. Microbiol. 29:533-538.
14. Balows, A., W. J. Hausler, Jr., K. L. Herrman, H. D. Isenberg, and H. J. Shadomy (ed.). 1991. Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
15. Bandres, J. C., and R. O. Darouiche. 1992. Staphylococcus capitis endocarditis: a new cause of an old disease. Clin. Infect. Dis. 14:366-367.
16. Bandyk, D. F., T. M. Bergamini, E. V. Kinney, G. R. Seabrook, and J. B. Towne. 1991. In situ replacement of vascular prostheses infected by bacterial biofilms. J. Vase. Surg. 13:575-583.
17. Bannerman, T. L., L. W. Ayers, and W. E. Kloos. 1993. Unpublished results.
18. Bannerman, T. L., K. T. Kleeman, and W. E. Kloos. 1993. Evaluation of Vitek Systems gram-positive identification card for species identification of coagulase-negative staphylococci. J. Clin. Microbiol. 31:1322-1325.
19. Bannerman, T. L., and W. E. Kloos. 1991. Staphylococcus capitis subsp. ureolyticus subsp. nov. from human skin. Int. J. Syst. Bacteriol. 41:144-147.
20. Bannerman, T. L., D. L. Wadiak, and W. E. Kloos. 1991. Susceptibility of Staphylococcus species and subspecies to teicoplanin. Antimicrob. Agents Chemother. 35:1919-1922.
21. Bannerman, T. L., D. L. Wadiak, and W. E. Kloos. 1991. Susceptibility of Staphylococcus species and subspecies to fleroxacin. Antimicrob. Agents Chemother. 35:2135-2139.
22. Barker, L. P., W. A. Simpson, and G. D. Christensen. 1990. Differential production of slime under aerobic and anaerobic conditions. J. Clin. Microbiol. 28:2578-2579.
23. Barry, A. L., M. A. Pfaller, and P. C. Fuchs. 1992. Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temafloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 11:243-246.
24. Baumgart, S., S. E. Hall, J. M. Campos, and R. A. Polin. 1983. Sepsis with coagulase-negative staphylococci in critically ill newborns. Am. J. Dis. Child. 137:461-463.
25. Bergamini, T. M., D. F. Bandyk, and D. Govostis. 1989. Identification of Staphylococcus epidermidis vascular graft infections: a comparison of culture techniques. J. Vase. Surg. 9:665-670.
26. Bergman, B., H. Wedren, and S. E. Holm. 1989. Staphylococcus saprophyticus in males with symptoms of chronic prostatitis. Urology 34:241-245.
27. Berkhoff, H. A., D. N. Ballard, W. E. Kloos, F. Götz, and E. Muller. 1983. Congo red agar test as an additional assay for detecting plastic adherence and virulence of coagulase-negative staphylococci, abstr. B-210, p. 63. Abstr. 93rd Gen. Meet. Am. Soc. Microbiol. 1993. American Society for Microbiology, Washington, D.C.
28. Beutler, B., and A. Cerami. 1989. The biology xf cachectic/ TNFα - a primary mediator of the host response. Annu. Rev. Immunol. 7:625-656.
29. Bialkowska-Hobrzanska, H., V. Harry, D. Jaskot, and O. Hammerberg. 1990. Typing of coagulase-negative staphylococci by southern hybridization of chromosomal DNA fingerprints using a ribosomal RNA probe. Eur. J. Clin. Microbiol. Infect. Dis. 9:588-594.
30. Bialkowska-Hobrzanska, H., O. Jaskot, and O. Hammerberg. 1990. Evaluation of restriction endonuclease fingerprinting of chromosomal DNA and plasmid profile analysis for characterization of multiresistant coagulase-negative staphylococci in bacteremic neonates. J. Clin. Microbiol. 28:269-275.
31. Biavasco, F., R. Lupidi, and P. E. Varaldo. 1992. In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873. Antimicrob. Agents Chemother. 36:331-338.
32. Bille, J., and M. P. Glauser. 1991. In-vitro activity of temafloxacin for gram-positive pathogens. J. Antimicrob. Chemother. 28(Suppl. C):9-14.
33. Birnbaum, D., M. Kelly, and A. W. Chow. 1991. Epidemiologic typing systems for coagulase-negative staphylococci. Infect. Control Hosp. Epidemiol. 12:319-326.
34. Bor, D. H., R. M. Rose, J. F. Modlin, R. Weintraub, and G. H. Friedland. 1983. Mediastinitis after cardiovascular surgery. Rev. Infect. Dis. 5:885-897.
35. Bowley, J. A., S. J. Pickering, A. J. Scantlebury, P. Ackrill, and D. M. Jones. 1988. Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. J. Antimicrob. Chemother. 21(Suppl. A):133-139.
36. Bowman, R. A., and M. Buck. 1984. Staphylococcus hominis septicaemia in patients with cancer. Med. J. Aust. 140:26-27.
37. Brandt, L., and B. Swahn. 1960. Subacute bacterial endocarditis due to coagulase-negative Staphylococcus albus. Acta Med. Scand. 166:125-132.
38. Brause, B. D. 1986. Infections associated with prosthetic joints. Clin. Rheum. Dis. 12:523-535.
39. Brown, A. L., J. R. Stephenson, L. R. I. Baker, and S. Tabaqchali. 1991. Recurrent CAPD peritonitis caused by coagulase-negative staphylococci: re-infection or relapse determined by clinical criteria and typing methods. J. Hosp. Infect. 18:109-122.
40. Brown, D. F. J., and L. Brown. 1991. Evaluation of the E test, a novel method of quantifying antimicrobial activity. J. Antimicrob. Chemother. 27:185-190.
41. Brunet, F., G. Vedel, F. Dreyfus, J. F. Vaxelaire, T. Giraud, B. Schremmer, and J. F. Monsallier. 1990. Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin. Eur. J. Clin. Microbiol. Infect. Dis. 9:145-147.
42. Bryan, C. S. 1989. Clinical implications of positive blood cultures. Clin. Microbiol. Rev. 2:329-353.
43. Caputo, G. M., G. L. Archer, S. B. Caulderwood, M. J. DiNubile, and A. W. Karchmer. 1987. Native valve endocarditis due to coagulase-negative staphylococci. Am. J. Med. 83:619-625.
44. Carlos, C. C., S. Ringertz, M. Rylander, P. Huovinen, and G. Faxelius. 1991. Nosocomial Staphylococcus epidermidis septicaemia among very low birth weight neonates in an intensive care unit. J. Hosp. Infect. 19:201-207.
45. Carson, C. C., V. D. McCraw, and P. Zwadyk, 1982. Bacterial prostatitis caused by Staphylococcus saprophyticus. Urology 19:576-578.
46. Chin, N., and H. C. Neu. 1991. In vitro activity of LY264826 compared to other glycopeptides and daptomycin. Diagn. Microbiol. Infect. Dis. 14:181-184.
47. Chomarat, M., D. Espinouse, and J.-P. Flandrois. 1991. Coagulase-negative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity. J. Antimicrob. Chemother. 27:475-480.
48. Choo, M. H., D. R. Holmes, B. J. Gersch, J. D. Maloney, J. Meredith, J. R. Pluth, and J. Trusty. 1981. Permanent pacemaker infections: characterization and management. Am. J. Cardiol. 48:559-564.
49. Christensen, G. D. 1987. The confusing and tenacious coagulase-negative staphylococci. Adv. Intern. Med. 32:177-192.
50. Christensen, G. D., J. T. Parisi, A. L. Bisno, W. A. Simpson, and E. H. Beachey. 1983. Characterization of clinically significant strains of coagulase-negative staphylococci. J. Clin. Microbiol. 18:258-269.
51. Christensen, G. D., W. A. Simpson, A. L. Bisno, and E. H. Beachey. 1982. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect. Immun. 37:318-326.
52. Christensen, G. D., W. A. Simpson, A. L. Bisno, and E. H. Beachey. 1983. Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect. Immun. 40:407-410.
53. Christensen, G. D., W. A. Simpson, J. J. Younger, L. M. Baddour, F. F. Barrett, D. M. Melton, and E. H. Beachey. 1986. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 22:996-1006.
54. Clarke, A. M. 1979. Prophylactic antibiotics for total hip arthroplasty - the significance of Staphylococcus epidermidis. J. Antimicrob. Chemother. 5:493-502.
55. Cleri, D. J., M. L. Corradi, and S. J. Seligman. 1980. Quantitative culture of intravenous catheters and other intravascular inserts. J. Infect. Dis. 141:781-786.
56. Clink, J., and T. H. Pennington. 1987. Staphylococcal wholecell polypeptide analysis: evaluation as a taxonomic and typing tool. J. Med. Microbiol. 23:41-44.
57. Colleen, S., B. Hovelius, Å. Wieslander, and P.-A. Mårdh. 1979. Surface properties of Staphylococcus saprophyticus and Staphylococcus epidermidis as studied by adherence tests and two-polymer, aqueous phase systems. Acta Pathol. Microbiol. Immunol. Scand. Sect. B 87:321-328.
58. Courtiss, E. H., R. M. Goldwyn, and G. W. Anastasi. 1979. The fate of breast implants with infections around them. Plast. Reconstr. Surg. 63:812.
59. Courvalin, P. 1990. Plasmid-mediated 4-quinolone resistance: a real or apparent absence? Antimicrob. Agents Chemother. 34:681-684.
60. Dan, M., G. J. R. Marien, and G. Goldsand. 1984. Endocarditis caused by Staphylococcus warneri on a normal aortic valve following vasectomy. Can. Med. Assoc. J. 131:211-213.
61. Dankert, J., A. H. Host, and J. Feijen. 1986. Biomedical polymers: bacterial adhesion colonization and infection, p. 219-301. In D. F. Williams (ed.), Critical reviews in biocompatibility, vol. 2. CRC Press, Boca Raton, Fla.
62. DeBuyser, M.-L., A. Morvan, F. Grimont, and N. El Solh. 1989. Characterization of Staphylococcus species by ribosomal RNA gene restriction patterns. J. Gen. Microbiol. 135:989-999.
63. Deighton, M., S. Pearson, J. Capstick, D. Spelman, and R. Borland. 1992. Phenotypic variation of Staphylococcus epidermidis isolated from a patient with native valve endocarditis. J. Clin. Microbiol. 30:2385-2390.
64. De La Fuente, R., G. Suarez, and K. H. Schleifer. 1985. Staphylococcus aureus subsp. anaerobius subsp. nov., the causal agent of abscess disease of sheep. Int. J. Syst. Bacteriol. 35:99-102.
65. Denyer, S. P., M. C. Davies, and J. A. Evans. 1990. Influence of carbon dioxide on the surface characteristics and adherence potential of coagulase-negative staphylococci. J. Clin. Microbiol. 28:1813-1817.
66. Devriese, L. A., V. Hájek, P. Oeding, S. A. Meyer, and K. H. Schleifer. 1978. Staphylococcus hyicus (Sompolinsky 1953) comb. nov. and Staphylococcus hyicus subsp. chromogenes subsp. nov. Int. J. Syst. Bacteriol. 28:482-490.
67. Devriese, L. A., B. Poutrel, R. Kilpper-Balz, and K. H. Schleifer. 1983. Staphylococcus gallinarum and Staphylococcus caprae, two new species from animals. Int. J. Syst. Bacteriol. 33:480-486.
68. Dinarello, C. A. 1989. Interleukin 1 and its biologically related cytokines. Adv. Immunol. 44:153-206.
69. Drewry, D. T., L. Galbraith, B. J. Wilkinson, and S. G. Wilkinson. 1990. Staphylococcal slime: a cautionary tale. J. Clin. Microbiol. 28:1292-1296.
70. Driebe, W. T., Jr., S. Mandelbaum, and R. K. Foster. 1986. Pseudophasic endophthalmitis - diagnosis and management. Ophthalmology 93:442.
71. Dryden, M. S., H. G. Talsania, S. Martin, M. Cunningham, J. F. Richardson, B. Cookson, R. R. Marples, and I. Phillips. 1992. Evaluation of methods for typing coagulase-negative staphylococci. J. Med. Microbiol. 37:109-117.
72. Dryden, M. S., H. Talsania, M. McCann, B. D. Cookson, and I. Phillips. 1992. The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients. Epidemiol. Infect. 109:97-112.
73. Endl, J., P. H. Seidl, F. Fiedler, and K. H. Schleifer. 1983. Chemical composition and structure of cell wall teichoic acids of staphylococci. Arch. Microbiol. 135:215-223.
74. Erwin, M. E., R. N. Jones, M. S. Barrett, B. M. Briggs, and D. M. Johnson. 1991. In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin. Antimicrob. Agents Chemother. 35:929-937.
75. Etienne, J., B. Pangon, C. Leport, M. Wolff, B. Clair, C. Perronne, Y. Brun, and A. Bure. 1989. Staphylococcus lugdunensis endocarditis. Lancet ii:1394.
76. Etienne, J., F. Renaud, M. Bes, Y. Brun, T. B. Greenland, J. Freney, and J. Fleurette. 1990. Instability of characteristics amongst coagulase-negative staphylococci causing endocarditis. J. Med. Microbiol. 32:115-122.
77. Evans, R. C., and C. J. Holmes. 1987. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob. Agents Chemother. 31:889-894.
78. Eykyn, S. J., W. R. Gransden, and I. Phillips. 1990. The causative organisms of septicaemia and their epidemiology. J. Antimicrob. Chemother. 25(Suppl. C):41-58.
79. Ferguson, D. A., Jr., E. M. Veringa, W. R. Mayberry, B. P. Overbeek, D. W. Lambe, Jr., and J. Verhoef. 1992. Bacteroides and Staphylococcus glycocalyx: chemical analysis, and the effects on chemiluminescence and chemotaxis of human polymorphonuclear leucocytes. Microbios 69:53-65.
80. Ferguson, K. P., D. W. Lambe, Jr., J. L. Keplinger, and J. H. Kalbfleish. 1991. Comparison of the pathogenicity of three species of coagulase-negative Staphylococcus in a mouse model with and without a foreign body. Can. J. Microbiol. 37:722-724.
81. Ferreirós, C. M., M. J. Souto, M. T. Criado, and P. Suárez. 1991. Phage typing and phage induction in carrier and invasive Staphylococcus epidermidis isolates. J. Hosp. Infect. 18:293-299.
82. Fleer, A., R. C. Senders, M. R. Visser, R. P. Bijlmer, L. J. Gerards, C. A. Kraaijeveld, and J. Verhoff. 1983. Septicemia due to coagulase-negative staphylococci in a neonatal intensive care unit: clinical and bacteriological features and contaminated parental fluids as a source of sepsis. Pediatr. Infect. Dis. 2:426-431.
83. Fleer, A., and J. Verhoef. 1989. An evaluation of the role of surface hydrophobicity and extracellular slime in the pathogenesis of foreign-body-related infections due to coagulase-negative staphylococci. J. Invest. Surg. 2:391-396.
84. Fleurette, J., M. Bès, Y. Brun, J. Freney, F. Forey, M. Coulet, M. E. Reverdy, and J. Etienne. 1989. Clinical isolates of Staphylococcus lugdunensis and S. schleifen: bacteriological characteristics and susceptibility to antimicrobial agents. Res. Microbiol. 140:107-118.
85. Fleurette, J., Y. Brun, M. Bès, M. Coulet, and F. Forey. 1987. Infections caused by coagulase-negative staphylococci other than S. epidermidis and S. saprophyticus, p. 195-208. In G. Pulverer, P. G. Qui, and G. Peters (ed.), Pathogenicity and clinical significance of coagulase-negative staphylococci. Gustav Fischer Verlag, Stuttgart, Germany.
86. Floyd-Reising, S., J. A. Hindler, and L. S. Young. 1987. In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents. Antimicrob. Agents Chemother. 31:640-642.
87. Flynn, P. M., J. L. Shenep, D. C. Stokes, and F. F. Barrett. 1987. In situ management of confirmed central venous catheter-related bacteremia. Pediatr. Infect. Dis. J. 6:729-734.
88. Forstall, G. J., C. C. Knapp, and J. A. Washington. 1991. Activity of new quinolones against ciprofloxacin-resistant staphylococci. Antimicrob. Agents Chemother. 35:1679-1681.
89. Freeman, J., R. Platt, M.-F. Epstein, N. E. Smith, D. G. Sidebottom, and D. A. Goldmann. 1990. Birth weight and length of stay as determinants of nosocomial coagulase-negative staphylococcal bacteremia in neonatal intensive care unit populations: potential for confounding. Am. J. Epidemiol. 132:1130-1140.
90. Freeman, J., R. Platt, D. G. Sidebottom, J. M. Leclair, M.-F. Epstein, and D. A. Goldmann. 1987. Coagulase-negative staphylococcal bacteremia in the changing neonatal intensive care unit population. JAMA 258:2548-2552.
91. Freeman, R., M. Goodfellow, A. C. Ward, S. J. Hudson, F. K. Gould, and N. F. Lightfoot. 1991. Epidemiological typing of coagulase-negative staphylococci by pyrolysis mass spectrometry. J. Med. Microbiol. 34:245-248.
92. Freeman, R., F. K. Gould, R. Wilkinson, A. C. Ward, N. F. Lightfoot, and P. R. Sisson. 1991. Rapid inter-strain comparison by pyrolysis mass spectrometry of coagulase-negative staphylococci from persistent CAPD peritonitis. Epidemiol. Infect. 106:239-246.
93. Freney, J., Y. Brun, M. Bès, H. Meugneir, F. Grimont, P. A. D. Grimont, C. Nervi, and J. Fleurette. 1988. Staphylococcus lugdunensis sp. nov. and Staphylococcus schleifen sp. nov., two species from human clinical specimens. Int. J. Syst. Bacteriol. 38:168-172.
94. Froggatt, J. W., J. L. Johnston, D. W. Galetto, and G. L. Archer. 1989. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob. Agents Chemother. 33:460-466.
95. Fu, K. P., S. C. Lafredo, B. Foleno, D. M. Isaacson, J. F. Barrett, A. J. Tobia, and M. E. Rosenthal. 1992. In vitro and in vivo antibacterial activities of levofloxacin (L-ofloxacin), an optically active ofloxacin. Antimicrob. Agents Chemother. 36:860-866.
96. Gallagher, D. J. A., J. Z. Montgomerie, and J. D. K. North. 1965. Acute infections of the urinary tract and the urethral sysrome in general practice. Br. Med. J. 1:622.
97. Gatermann, S., J. John, and R. Marre. 1989. Staphylococcus urease: characterization and contribution to uropathogenicity in unobstructed urinary tract infection of rats. Infect. Immun. 57:110-116.
98. Gatermann, S., B. Kreft, R. Marre, and G. Wanner. 1992. Identification and characterization of a surface-associated protein (Ssp) of Staphylococcus saprophyticus. Infect. Immun. 60:1055-1060.
99. George, C. G., and W. E. Kloos. Comparison of the SmaI-digested chromosomes of Staphylococcus epidermidis and the closely related species Staphylococcus capitis and Staphylococcus caprae. Submitted for publication.
100. George, R., L. Leibrock, and M. Epstein. 1979. Long term analysis of cerebrospinal fluid shunt infections: a 25-year experience. J. Neurosurg. 51:804-811.
101. George, R. C., L. C. Ball, and P. B. Norbury. 1990. Susceptibility to ciprofloxacin of nosocomial gram-negative bacteria and staphylococci isolated in the UK. J. Antimicrob. Chemother. 26(Suppl. F):145-156.
102. Gill, V. J., S. T. Selepak, and E. C. Williams. 1983. Species identification and antibiotic susceptibilities of coagulase-negative staphylococci isolated from clinical specimens. J. Clin. Microbiol. 18:1314-1319.
103. Glimåker, M., C. Granert, and A. Krook. 1988. Septicemia caused by Staphylococcus saprophyticus. Scand. J. Infect. Dis. 20:347-348.
104. Goering, R. V., and T. D. Duensing. 1990. Rapid field inversion gel electrophoresis in combination with an rRNA gene probe in the epidemiological evaluation of staphylococci. J. Clin. Microbiol. 28:426-429.
105. Goering, R. V., and M. A. Winters. 1992. Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis. J. Clin. Microbiol. 30:577-580.
106. Gokal, R. 1982. Peritonitis in continuous ambulatory dialysis. J. Antimicrob. Chemother. 9:417-422.
107. Goldenring, J. M. 1986. Staphylococcus saprophyticus urinary tract infection in an American college student. J. Adol. Health Care 7:417-418.
108. Goldenring, J. M. 1988. Staphylococcus saprophyticus urinary tract infection in a sexually abused child. Pediatr. Infect. Dis. J. 7:73-74.
109. Goldstein, F. W., A. Coutrot, A. Sieffer, and J. F. Acar, 1990. Percentages and distributions of teicoplanin and vancomycinresistant strains among coagulase-negative staphylococci. Antimicrob. Agents Chemother. 34:899-900.
110. Golledge, C. L. 1988. Staphylococcus saprophyticus bacteremia. J. Infect. Dis. 157:215.
111. Gray, E. D., G. Peters, M. Verstegen, and W. E. Regelmann. 1984. Effects of extracellular slime substance from Staphylococcus epidermidis on the cellular immune response. Lancet i:365-367.
112. Gray, E. D., W. E. Regelmann, and G. Peters. 1987. Staphylococcal slime and host defenses: effects on lymphocytes and immune function, p. 45-54. In G. Pulverer, P. G. Quie, and G. Peters (ed.), Pathogenicity and clinical significance of coagulase-negative staphylococci. Gustav Fischer Verlag, Stuttgart, Germany.
113. Grosserode, M. H., and R. P. Wenzel. 1991. The continuing importance of staphylococci as major hospital pathogens. J. Hosp. Infect. 19(Suppl. B):3-17.
114. Gruer, L. D., R. Bartlett, and G. A. J. Ayliffe. 1984. Species identification and antimicrobic sensitivity of coagulase-negative staphylococci from CAPD peritonitis. J. Antimicrob. Chemother. 13:577-583.
115. Hájek, V. 1976. Staphylococcus intermedius, a new species isolated from animals. Int. J. Syst. Bacteriol. 26:401-408.
116. Hájek, V., L. A. Devriese, M. Mordarski, M. Goodfellow, G. Pulverer, and P. E. Veraldo. 1986. Elevation of Staphylococcus hyicus subsp. chromogenes (Devriese et al. 1978) to species status: Staphylococcus chromogenes (Devriese et al. 1978) comb. nov. Syst. Appl. Microbiol. 8:169-173.
117. Hájek, V., W. Ludwig, K. H. Schleifer, N. Springer, W. Zitzelsberger, R. M. Kroppenstedt, and M. Kocur. 1992. Staphylococcus muscae, a new species isolated from flies. Int. J. Syst. Bacteriol. 42:97-101.
118. Hamilton-Miller, J. M. T. 1992. In vitro activities of 14-, 15-, and 16-membered macrolides against gram-positive cocci. J. Antimicrob. Chemother. 29:141-147.
119. Harding, I., and J. J. Garaud. 1988. Teicoplanin in the treatment of infections caused by coagulase-negative staphylococci. J. Antimicrob. Chemother. 21(Suppl. A):93-103.
120. Hébert, G. A. 1989. Antimicrobic susceptibility and other phenotypic tests that help identify and biotype coagulase-negative staphylococci. Antimicrob. Newsl. 6:9-17.
121. Hébert, G. A. 1990. Hemolysins and other characteristics that help differentiate and biotype Staphylococcus lugdunensis and Staphylococcus schleiferi. J. Clin. Microbiol. 28:2425-2431.
122. Hébert, G. A., R. C. Cooksey, N. C. Clark, B. C. Hill, W. R. Jarvis, and C. Thornsberry. 1988. Biotyping coagulase-negative staphylococci. J. Clin. Microbiol. 26:1950-1956.
123. Hedman, P., and O. Ringertz. 1991. Urinary tract infections caused by Staphylococcus saprophyticus. A matched case control study. J. Infect. 23:145-153.
124. Herwaldt, L. A., L. D. Boyken, and M. A. Pfaller. 1990. Biotyping of coagulase-negative staphylococci: 108 isolates from nosocomial bloodstream infections. Diagn. Microbiol. Infect. Dis. 13:461-466.
125. Herwaldt, L. A., L. Boyken, and M. Pfaller. 1991. In vitro selection of resistance to vancomycin in bloodstream isolates of Staphylococcus haemolyticus and Staphylococcus epidermidis. Eur. J. Clin. Microbiol. Infect. Dis. 10:1007-1012.
126. Hjelm, E., and I. Lundell-Etherden. 1991. Slime production by Staphylococcus saprophyticus. Infect. Immun. 59:445-448.
127. Hjelm, E., A. Schwan, I. Lundell-Etherden, and T. Sandberg. 1990. Antibody response to Staphylococcus saprophyticus in urinary tract infection. Scand. J. Infect. Dis. 22:557-560.
128. Hodinka, R. L., K. Jack-Wait, and P. H. Gilligan. 1987. Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic. Eur. J. Clin. Microbiol. 6:103-108.
129. Hogt, A. H., J. Dankert, C. E. Hulstaert, and J. Feijen. 1986. Cell surface characteristics of coagulase-negative staphylococci and their adherence to fluorinated poly(ethylenepropylene). Infect. Immun. 51:294-301.
130. Hogt, A. H., J. Dankert, J. A. Vries, and J. Feijen. 1983. Adhesion of coagulase-negative staphylococci to biomaterials. J. Gen. Microbiol. 129:2959-2968.
131. Holt, R. J. 1971. The colonization of ventriculoatrial shunts by coagulase-negative staphylococci, p. 81-87. In M. Finland, W. Marget, and K. Bartmann (ed.), Bacterial infections: changes in their causative agents, trends and possible basis. Springer-Verlag, Stuttgart, Germany.
132. Hovelius, B. 1986. Epidemiological and clinical aspects of urinary tract infections caused by Staphylococcus saprophyticus, p. 195-202. In P.-A. Mårdh and K. H. Schleifer (ed.), Coagulase-negative staphylococci. Almqvist and Wiksell International, Stockholm.
133. Huang, M. B., C. N. Baker, S. Banerjee, and F. C. Tenover. 1992. Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents. J. Clin. Microbiol. 30:3243-3248.
134. Hussain, M., C. Collins, J. G. M. Hastings, and P. J. White. 1992. Radiochemical assay to measure the biofilm produced by coagulase-negative staphylococci on solid surfaces and its use to quantitate the effects of various antibacterial compounds on the formation of the biofilm. J. Med. Microbiol. 37:62-69.
135. Hussain, M., J. G. M. Hastings, and P. J. White. 1991. A chemically defined medium for slime production by coagulase-negative staphylococci. J. Med. Microbiol. 34:143-147.
136. Hussain, M., J. G. M. Hastings, and P. J. White. 1991. Isolation and composition of the extracellular slime made by coagulase-negative staphylococci in a chemically defined medium. J. Infect. Dis. 163:534-541.
137. Hussein, M., J. G. M. Hastings, and P. J. White. 1992. Comparison of cell-wall teichoic acid with high-molecular-weight extracellular slime material from Staphylococcus epidermidis. J. Med. Microbiol. 37:368-375.
138. Hussain, M., M. H. Wilcox, P. J. White, M. K. Faulkner, and R. C. Spencer. 1992. Importance of medium and atmosphere type to both slime production and adherence by coagulase-negative staphylococci. J. Hosp. Infect. 20:173-184.
139. Igimi, S., S. Kawamura, E. Takahashi, and T. Mitsuoka. 1989. Staphylococcus felis, a new species from clinical specimens from cats. Int. J. Syst. Bacteriol. 39:373-377.
140. Igimi, S., E. Takahashi, and T. Mitsuoka. 1990. Staphylococcus schleifen subsp. coagulans subsp. nov., isolated from the external auditory meatus of dogs with external ear otitis. Int. J. Syst. Bacteriol. 40:409-411.
141. Isenberg, H., J. A. Washington II, A. Balows, and A. C. Sonnenwirth. 1985. Collection, handling, and processing of specimens, p. 73-98. In E. H. Lennette, A. Balows, W. J. Hausler, Jr., and H. J. Shadomy (ed.), Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C.
142. Izard, N. C., H. Hächler, M. Grehn, and F. H. Kayser. 1992. Ribotyping of coagulase-negative staphylococci with special emphasis on intraspecific typing of Staphylococcus epidermidis. J. Clin. Microbiol. 30:817-823.
143. Jansen, B., F. Schumacher-Perdreau, G. Peters, and G. Pulverer. 1989. New aspects in the pathogenesis and prevention of polymer-associated foreign-body infections caused by coagulase-negative staphylococci. J. Invest. Surg. 2:361-380.
144. Jansen, B., F. Schumacher-Perdreau, G. Peters, G. Reinhold, and J. Schönemann. 1992. Native valve endocarditis caused by Staphylococcus simulans. Eur. J. Clin. Microbiol. Dis. 11:268-269.
145. Jarvis, W. R., and W. J. Martone. 1992. Predominant pathogens in hospital infections. J. Antimicrob. Chemother. 29 (Suppl. A):19-24.
146. Jean-Pierre, H., H. Darbas, A. Jean-Roussenq, and G. Boyer. 1989. Pathogenicity in two cases of Staphylococcus schleifen, a recently described species. J. Clin. Microbiol. 27:2110-2111.
147. Jenssen, W. D., S. Thakker-Varia, D. T. Dubin, and M. P. Weinstein. 1987. Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob. Agents Chemother. 31:883-888.
148. John, J. F., P. K. Gramling, and N. M. O'Dell. 1978. Species identification of coagulase-negative staphylococci from urinary tract infections. J. Clin. Microbiol. 8:435-437.
149. Johnson, A. P., A. H. C. Uttley, N. Woodford, and R. C. George. 1990. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin. Microbiol. Rev. 3:280-291.
150. Johnson, G. M., W. E. Regelmann, E. D. Gray, G. Peters, and P. G. Quie. 1987. Staphylococcal slime and host defenses: effects on polymorphonuclear granulocytes, p. 33-44. In G. Pulverer, P. G. Quie, and G. Peters (ed.), Pathogenicity and clinical significance of coagulase-negative staphylococci. Gustav Fischer Verlag, Stuttgart, Germany.
151. Johnson, G. M., W. E. Regelmann, E. D. Gray, P. G. Quie, and G. Peters. 1984. Effects of Staphylococcal epidermidis slime on PMN chemotaxis and degranulation, abstr. 55, p. 99. Program Abstr. 24th Intersci. Conf. Antimicrob. Agents Chemother.
152. Jones, R. N., M. E. Erwin, M. S. Barrett, D. M. Johnson, and B. M. Briggs. 1991. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems. Diagn. Microbiol. Infect. Dis. 14:301-309.
153. Jones, R. N., F. W. Goldstein, and X. Y. Zhou. 1991. Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States. Antimicrob. Agents Chemother. 35:584-586.
154. Jones, R. N., M. A. Pfaller, S. D. Allen, E. H. Gerlach, P. C. Fuchs, and K. E. Aldridge. 1991. Antimicrobial activity of cefpirome: an update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers. Diagn. Microbiol. Infect. Dis. 14:361-364.
155. Kamath, U., C. Singer, and H. D. Isenberg. 1992. Clinical significance of Staphylococcus warnen bacteremia. J. Clin. Microbiol. 30:261-264.
156. Kamme, C., and L. Lindberg. 1981. Aerobic and anaerobic bacteria in deep infections after total hip arthroplasty: differential diagnosis. Clin. Orthop. Surg. 154:202-207.
157. Kanda, K., E. Suzuki, K. Hiramatsu, T. Oguri, H. Miura, T. Ezaki, and T. Yokota. 1991. Identification of a methicillin-resistant strain of Staphylococcus caprae from a human clinical specimen. Antimicrob. Agents Chemother. 35:174-176.
158. Karchmer, A. W., and G. M. Caputo. 1986. Endocarditis due to coagulase-negative staphylococci, p. 179-187. In P.-A. Mårdb and K. H. Schleifer (ed.), Coagulase-negative staphylococci. Almquist and Wiskell International, Stockholm.
159. Karthigasu, K. T., R. A. Bowman, and D. I. Grove. 1986. Vertebral osteomyelitis due to Staphylococcus worneri. Ann. Rheum. Dis. 45:1029-1030.
160. Kass, E. H. 1956. Asymptomatic infections of the urinary tract. Trans. Assoc. Am. Physicians 69:56-64.
161. Kenny, M. T., G. D. Mayer, J. K. Dulworth, M. A. Brackman, and K. Farrar. 1992. Evaluation of the teicoplanin broth microdilution and disk diffusion susceptibility tests and recommended interpretive criteria. Diagn. Microbiol. Infect. Dis. 15:609-612.
162. Kilpper-Bälz, R., and K. H. Schleifer. 1981. Transfer of Peptococcus saccharolyticus Foubert and Douglas to the genus Staphylococcus: Staphylococcus saccharolyticus (Foubert and Douglas) comb. nov. Zentralbl. Bakteriol. Hyg. Abt. 1 Orig. Reihe C 2:324-331.
163. King, A., C. Boothman, and I. Phillips. 1990. Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins. Eur. J. Clin. Microbiol. Infect. Dis. 9:677-685.
164. Kleeman, K. T., T. L. Bannerman, and W. E. Kloos. 1993. Species distribution of coagulase-negative staphylococcal isolates at a community hospital and implications for selection of staphylococcal identification procedures. J. Clin. Microbiol. 31:1318-1321.
165. Kloos, W. E. 1986. Ecology of human skin, p. 37-50. In P.-A. Mårdh and K. H. Schleifer (ed.), Coagulase-negative staphylococci. Almquist and Wiksell International, Stockholm.
166. Kloos, W. E. 1986. Community structure of coagulase-negative staphylococci in humans, p. 132-138. In L. Leive (ed.), Microbiology - 1986. American Society for Microbiology, Washington, D.C.
167. Kloos, W. E. 1990. Systematics and the natural history of staphylococci. I. J. Appl. Bacteriol. Symp. Suppl. 69:25S-37S.
168. Kloos, W. E., H. A. Berkhoff, E. Muller, T. L. Bannerman, and D. N. Ballard. 1992. Relationship between cutaneous persistence in natural populations of coagulase-negative staphylococci and their ability to produce catheter infections, biofilm, and polysaccharide adhesin, abstr. B-240, p. 66. Abstr. 92nd Gen. Meet. Am. Soc. Microbiol. 1992. American Society for Microbiology, Washington, D.C.
169. Kloos, W. E., and C. G. George. 1991. Identification of Staphylococcus species and subspecies with the Microscan Pos ID and Rapid Pos ID Panel Systems. J. Clin. Microbiol. 29:738-744.
170. Kloos, W. E., C. G. George, and L. A. Jones-Park. 1992. Effect of topical clindamycin therapy on cutaneous Staphylococcus species, abstr. A-60, p. 11. Abstr. 92nd Gen. Meet. Am. Soc. Microbiol. 1992. American Society for Microbiology, Washington, D.C.
171. Kloos, W. E., and D. W. Lambe, Jr. 1991. Staphylococcus, p. 222-237. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
172. Kloos, W. E., and M. S. Musselwhite. 1975. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl. Microbiol. 30: 381-395.
173. Kloos, W. E., and K. H. Schleifer. 1975. Isolation and characterization of staphylococci from human skin. II. Descriptions of four new species: Staphylococcus warneri, Staphylococcus capitis, Staphylococcus hominis, and Staphylococcus simulans. Int. J. Syst. Bacteriol. 25:62-79.
174. Kloos, W. E., and K. H. Schleifer. 1983. Staphylococcus auricularis sp. nov.: an inhabitant of the human external ear. Int. J. Syst. Bacteriol. 33:9-14.
175. Kloos, W. E., K. H. Schleifer, and F. Götz. 1991. The genus Staphylococcus, p. 1369-1420. In A. Balows, H. G. Trüper, M. Dworkin, W. Harder, and K. H. Schleifer (ed.), The prokaryotes. Springer-Verlag, New York.
176. Kloos, W. E., K. H. Schleifer, and R. F. Smith. 1976. Characterization of Staphylococcus sciuri sp. nov. and its subspecies. Int. J. Syst. Bacteriol. 26:22-37.
177. Kloos, W. E., and J. F. Wolfshohl. 1991. Staphylococcus cohnii subspecies: Staphylococcus cohnii subsp. cohnii subsp. nov. and Staphylococcus cohnii subsp. urealyticum subsp. nov. Int. J. Syst. Bacteriol. 41:284-289.
178. Kluge, R. M., F. M. Calia, and D. S. McLoughlin. 1974. Sources of contamination in open heart surgery. JAMA 230: 1415-1428.
179. Kojima, Y., M. Tojo, D. A. Goldmann, T. D. Tosteson, and G. B. Pier. 1990. Antibody to the capsular polysaccharide/ adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci. J. Infect. Dis. 162: 435-441.
180. Kotilainen, P., P. Huovinen, and E. Eerola. 1991. Application of gas-liquid Chromatographic analysis of cellular fatty acids for species identification and typing of coagulase-negative staphylococci. J. Clin. Microbiol. 29:315-322.
181. Kotilainen, P., J. Nikoskelainen, and P. Huovinen. 1990. Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J. Infect. Dis. 161:41-44.
182. Kraus, E. S., and D. A. Spector. 1983. Characteristics and sequelae of peritonitis in diabetics and nondiabetics receiving chronic intermittent peritoneal dialysis. Medicine (Baltimore) 62:52-57.
183. Krieger, J. N., and L. A. McGonagle. 1989. Diagnostic considerations and interpretation of microbiological findings for evaluation of chronic prostatitis. J. Clin. Microbiol. 27:2240-2244.
184. Kunin, C. M. 1987. Detection, prevention and management of urinary tract infections, 4th ed. Lea and Febiger, Philadelphia.
185. Lambe, D. W., Jr., H. Berkhoff, K. P. Ferguson, W. E. Kloos, T. L. Bannerman, and D. N. Ballard. 1993. Three mouse models for induction of subcutaneous abscesses by Staphylococcus species, abstr. 631, p. 176. Abstr. 6th Eur. Congr. Clin. Microbiol. Infect. Dis.
186. Lambe, D. W., Jr., K. P. Ferguson, C. G. Gemmell, and J. L. Keplinger. 1990. Pathogenic studies on five species of coagulase-negative staphylococci: a mouse model with a foreign body implant, p. 255-263. In T. Wadström, I. Eliasson, I. Holder, and A. Ljungh (ed.), Pathogenesis of wound and biomaterial-associated infections. Springer-Verlag, Berlin.
187. Lambe, D. W., Jr., K. P. Ferguson, J. L. Keplinger, C. G. Gemmell, and J. H. Kalbfleisch. 1990. Pathogenicity of Staphylococcus lugdunensis, Staphylococcus schleifen, and three other coagulase-negative staphylococci in a mouse model and possible virulence factors. Can. J. Microbiol. 36:455-463.
188. Lambe, D. W., Jr., K. P. Ferguson, K. J. Mayberry-Carson, B. Tober-Meyer, and J. W. Costerton. 1991. Foreign-body-associated experimental osteomyelitis induced with Bacteroides fragilis and Staphylococcus epidermidis in rabbits. Clin. Orthop. Relat. Res. 266:285-294.
189. Lambe, D. W., Jr., K. J. Mayberry-Carson, B. Tober-Meyer, J. W. Costerton, and K. P. Ferguson. 1987. A comparison of the effect of clindamycin and cefazolin on subcutaneous abscesses induced with Staphylococcus epidermidis and a foreign body implant in the mouse. Zentralbl. Bakteriol. Mikrobiol. Hyg. Abt. 1 Suppl. 16:275-286.
190. Latham, R. H., K. Running, and W. E. Stamm. 1983. Urinary tract infections in young adult women caused by Staphylococcus saprophyticus. JAMA 250:3063-3066.
191. Lee, W., R. J. Carpenter, L. E. Phillips, and S. Faro. 1987. Pyelonephritis and sepsis due to Staphylococcus saprophyticus. J. Infect. Dis. 155:1079-1080.
192. Leighton, P. M., and J. A. Little. 1986. Identification of coagulase-negative staphylococci isolated from urinary tract infections. Am. J. Clin. Pathol. 85:92-95.
193. Leitner, F., T. A. Pursiano, R. E. Buck, Y. H. Tsai, D. R. Chisholm, M. Misiek, J. V. Desiderio, and R. E. Kessler. 1987. BMY 28100, a new oral cephalosporin. Antimicrob. Agents Chemother. 31:238-243.
194. Lennette, E. H., A. Balows, W. J. Hausler, Jr., and H. J. Shadomy (ed.). 1985. Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C.
195. Lina, B., M. Celard, F. Vandenesch, A. Ribier, J. Delahaye, and J. Etienne. 1992. Infective endocarditis due to Staphylococcus capitis. Clin. Infect. Dis. 15:173-174.
196. Linares, J., A. Sitges-Serra, J. Garau, J. L. Perez, and M. Rogelio. 1985. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J. Clin. Microbiol. 21:357-360.
197. Low, D. E., A. McGeer, and R. Poon. 1989. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations. Antimicrob. Agents Chemother. 33:585-588.
198. Low, D. E., B. K. Schmidt, H. M. Kirpalani, R. Moodie, B. Kreiswirth, A. Matlow, and E. L. Ford-Jones. 1992. An endemic strain of Staphylococcus haemolyticus colonizing and causing bacteremia in neonatal intensive care unit patients. Pediatrics 89:696-700.
199. Ludlam, H. A., W. C. Noble, R. R. Marples, and I. Phillips. 1989. The evaluation of a typing scheme for coagulase-negative staphylococci suitable for epidemiological studies. J. Med. Microbiol. 30:161-165.
200. Ludwicka, A., B. Jansen, T. Wadström, L. Switalski, G. Peters, and G. Pulverer. 1984. Attachment of staphylococci to various synthetic polymers. Zentralbl. Bakteriol. Mikrobiol. Hyg. 256: 479-489.
201. Mabeck, C. E. 1969. Significance of coagulase-negative staphylococcal bacteriuria. Lancet ii:1150-1152.
202. Maggs, A. F., and T. H. Pennington. 1989. Temporal study of staphylococcal species on the skin of human subjects in isolation and clonal analysis of Staphylococcus capitis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J. Clin. Microbiol. 27:2627-2632.
203. Maki, D., C. E. Weise, and H. W. Safarin. 1977. A semiquantitative culture method for identifying intravenous-catheter-related infection. N. Engl. J. Med. 296:1305-1309.
204. Males, B. M., W. R. Bartholomew, and D. Amsterdam. 1985. Staphylococcus simulans: septicemia in a patient with chronic osteomyelitis and pyarthrosis. J. Clin. Microbiol. 21:255-257.
205. Mårdh, P.-A., S. Collen, and B. Hovelius. 1979. Attachment of bacteria to exfoliated cells from the urogenital tract. Invest. Urol. 16:322-325.
206. Marrie, T. J., C. Kwan, M. A. Noble, A. West, and L. Duffield. 1982. Staphylococcus saprophyticus as a cause of urinary tract infections. J. Clin. Microbiol. 16:427-431.
207. Martin, M. A., M. A. Pfaller, and R. P. Wenzel. 1989. Coagulase-negative staphylococcal bacteremia. Ann. Intern. Med. 110:9-16.
208. Maskell, J. P., A. M. Sefton, and J. D. Williams. 1990. Comparative in vitro activity of azithromycin and erythromycin against gram-positive cocci, Haemophilus influenzae and anaerobes. J. Antimicrob. Chemother. 25(Suppl. A):19-24.
209. Masur, H., and W. D. Johnson. 1980. Prosthetic valve endocarditis. J. Thorac. Cardiovasc. Surg. 80:31-37.
210. Mayberry-Carson, K. J., B. Tober-Meyer, L. R. Gill, D. W. Lambe, Jr., and F. E. Hossler. 1990. Effect of ciprofloxacin on experimental osteomyelitis in the rabbit tibia, induced with a mixed infection of Staphylococcus epidermidis and Bacteroides thetaiotaomicron. Microbios 64:49-66.
211. Mayberry-Carson, K. J., B. Tober-Meyer, L. R. Gill, D. W. Lambe, Jr., and W. R. Mayberry. 1988. Effect of ciprofloxacin on subcutaneous abscesses induced with Staphylococcus epidermidis and a foreign body implant in the mouse. Microbios 54:45-59.
212. McCabe, W. R., T. L. Treadwell, and A. DeMaria, Jr. 1983. Pathophysiology of bacteremia. Am. J. Med. 1983(Suppl.):7-18.
213. McCarthy, J. S., P. A. Stanley, and B. Mayall. 1990. A case of Staphylococcus simulans endocarditis affecting a native heart valve. J. Infect. 22:211-212.
214. Mclean, R., J. C. Nickel, V. Noakes, and W. Costerton. 1985. An in vitro ultrastructural study of infectious kidney stone genesis. Infect. Immun. 49:805-811.
215. Meares, E. M., Jr. 1980. Prostatitis syndromes: new perspectives above old woes. J. Urol. 123:141-147.
216. Meares, E. M., Jr., and T. A. Stamey. 1968. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest. Urol. 5:492-518.
217. Mickelson, P. A., J. J. Plorde, and K. P. Gordon. 1985. Instability of antibiotic resistance in a strain of Staphylococcus epidermidis isolated from an outbreak of prosthetic valve endocarditis. J. Infect. Dis. 152:50-58.
218. Morris, I. M., P. C. Mattingly, and B. E. Gostelow. 1986. Coagulase-negative Staphylococcus as a cause of joint infection. Br. J. Rheum. 25:414-415.
219. Muller, E., J. Hübner, N. Gutierrez, S. Takeda, D. A. Goldmann, and G. B. Pier. 1993. Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect. Immun. 61:551-558.
220. Murakami, K., W. Minamide, K. Wada, E. Nakamura, H. Teraoka, and S. Watanabe. 1991. Identification of methicillinresistant strains of staphylococci by polymerase chain reaction. J. Clin. Microbiol. 29:2240-2244.
221. Muratani, T., M. Inoue, and S. Mitsuhashi. 1992. In vitro activity of T-3761, a new fluoroquinolone. Antimicrob. Agents Chemother. 36:2293-2303.
222. Musser, J., P. M. Schlievert, A. W. Chow, P. Ewan, B. N. Kreiswirth, V. T. Rosdahl, A. S. Naidu, W. Witte, and R. K. Selander. 1990. A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc. Natl. Acad. Sci. USA 87:225-229.
223. Myrvik, Q. N., W. Wagner, E. Barth, P. Wood, and A. G. Gristina. 1989. Effects of extracellular slime produced by Staphylococcus epidermidis on oxidative responses of rabbit alveolar macrophages. J. Invest. Surg. 2:381-389.
224. Neu, H. C. 1988. Bacterial resistance to fluoroquinolones. Rev. Infect. Dis. 10(Suppl. 1):57-63.
225. Neu, H. C., N. X. Chin, and W. W. Niu. 1992. In vitro activity of the new glycopeptide decaplanin. Eur. J. Clin. Microbiol. Infect. Dis. 11:458-461.
226. Ngui-Yen, J. H., E. A. Bryce, C. Porter, and J. A. Smith. 1992. Evaluation of the E test by using selected gram-positive bacteria. J. Clin. Microbiol. 30:2150-2152.
227. Nickel, J. C., and J. W. Costerton. 1992. Coagulase-negative Staphylococcus in chronic prostatitis. J. Urol. 147:398-401.
228. Nickel, J. C., J. Emtage, and W. Costerton. 1985. Ultrastructural microbial ecology of infection-induced urinary stones. J. Urol. 133:622-627.
229. Nord, C. E., S. Holta-Oie, Å. Ljungh, and T. Wadström. 1976. Characterization of coagulase-negative staphylococcal species from human infections, p. 105-111. In J. Jeljaszewicz (ed.), Staphylococcus and staphylococcal diseases. Gustav Fischer Verlag, Stuttgart, Germany.
230. O'Day, D. M., D. B. Jones, J. Patrinely, and J. H. Elliott. 1982. Staphylococcus epidermidis endophthalmitis. Visual outcome following noninvasive therapy. Ophthalmology 89:354-360.
231. Ohshima, Y., F. Schumacher-Perdreau, G. Peters, P. G. Quie, and G. Pulverer. 1990. Antiphagocytic effect of the capsule of Staphylococcus simulans. Infect. Immun. 58:1350-1354.
232. Pagano, L., L. M. Larocca, R. Marra, E. Pizzigallo, and G. Leone. 1992. A leukemic patient with hepatosplenic abscesses due to coagulase-negative staphylococci. Clin. Infect. Dis. 14:364-365.
233. Paley, D., C. F. Moseley, P. Armstrong, and C. G. Prober. 1986. Primary osteomyelitis caused by coagulase-negative staphylococci. J. Pediatr. Orthop. 6:622-626.
234. Parisi, J. 1985. Coagulase-negative staphylococci and the epidemiological typing of Staphylococcus epidermidis. Microbiol. Rev. 49:126-139.
235. Pascual, A., A. Fleer, N. A. C. Westerdaal, and J. Verhoef. 1986. Modulation of adherence of coagulase-negative staphylococci to teflon catheters in vitro. Eur. J. Clin. Microbiol. 5:518-522.
236. Patrick, C. C. 1990. Coagulase-negative staphylococci: pathogens with increasing clinical significance. J. Pediatr. 116:497-507.
237. Paulsson, M., Å. Ljungh, and T. Wadström. 1992. Rapid identification of fibronectin, vitronectin, laminin, and collagen cell surface binding proteins on coagulase-negative staphylococci by particle agglutination assays. J. Clin. Microbiol. 30:2006-2112.
238. Paulsson, M., A.-C. Petersson, and Å. Ljungh. 1993. Serum and tissue protein binding and cell surface properties of Staphylococcus lugdunensis. J. Med. Microbiol. 38:96-102.
239. Paulsson, M., and T. Wadström. 1990. Vitronectin and type-I collagen binding by Staphylococcus aureus and coagulase-negative staphylococci. FEMS Microbiol. Immunol. 65:55-62.
240. Pereira, A. T. 1962. Coagulase-negative strains of Staphylococcus possessing antigen 51 as agents of urinary infection. J. Clin. Pathol. 15:252-259.
241. Pereira, A. T., and J. A. G. Melo Cristino. 1991. Phage typing of Staphylococcus saprophyticus. Epidemiol. Infect. 107:557-563.
242. Peters, G., R. Locci, and G. Pulverer. 1982. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J. Infect. Dis. 146:479-482.
243. Peters, G., F. Saborowski, R. Locci, and G. Pulverer. 1984. Investigations on staphylococcal infection of intravenous endocardial pacemaker-electrodes. Am. Heart J. 108:359-364.
244. Peters, G., F. Schumacher-Perdreau, B. Jansen, M. Bey, and G. Pulverer. 1987. Biology of S. epidermidis extracellular slime, p. 15-32. In G. Pulverer, P. G. Quie, and G. Peters (ed.), Pathogenicity and clinical significance of coagulase-negative staphylococci. Gustav Fischer Verlag, Stuttgart, Germany.
245. Pfaller, M. A. 1992. Molecular epidemiologic typing of nosocomial pathogens. Hoechst Clin. Microbiol. Updates 4:1-7.
246. Pfaller, M. A., and L. A. Herwaldt. 1988. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin. Microbiol. Rev. 1:281-299.
247. Pfaller, M. A., and R. J. Hollis. 1989. Use of plasmid profiles and restriction endonuclease analysis of plasmid DNA as epidemiologic and diagnostic tools in the clinical microbiology laboratory. Clin. Microbiol. Newsl. 11:137-142.
248. Pfau, A. 1983. Bacterial prostatitis caused by Staphylococcus saprophyticus. Urology 21:102-103.
249. Phillips, G., and C. L. Golledge. 1992. Vancomycin and teicoplanin: something old, something new. Med. J. Aust. 156:53-57.
250. Pierre, J., R. Williamson, M. Bornet, and L. Gutmann. 1990. Presence of an additional penicillin-binding protein in methicillin-resistant Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, and Staphylococcus simulans with a low affinity for methicillin, cephalothin, and cefamandole. Antimicrob. Agents Chemother. 34:1691-1694.
251. Platt, R. 1983. Quantitative definition of bacteriuria. Am. J. Med. 75(Suppl. 1B):44-52.
252. Plaunt, M. R., and C. C. Patrick. 1991. Identification of the innate human immune response to surface-exposed proteins of coagulase-negative staphylococci. J. Clin. Microbiol. 29:857-861.
253. Predari, S. C., M. Ligozzi, and R. Fontana. 1991. Genotypic identification of methicillin-resistant coagulase-negative staphylococci by polymerase chain reaction. Antimicrob. Agents Chemother. 35:2568-2573.
254. Pulverer, G. 1985. On the pathogenicity of coagulase-negative staphylococci, p. 1-9. In J. Jeljaszewics (ed.), The staphylococci: proceedings of V International Symposium on Staphylococci and Staphylococcal Infections. Gustav Fischer Verlag, Stuttgart, Germany.
255. Pulverer, G., and R. Halswick. 1967. Coagulase-negative Staphylokken (Staphylococcus albus) als Krankheitserreger. Dtsch. Med. Wochenschr. 92:1141-1145.
256. Pulverer, G., and J. Pillich. 1971. Pathogenic significance of coagulase-negative staphylococci, p. 91-96. In M. Finland, W. Marget, and K. Bartmann (ed.), Bacterial infections: changes in their causative agents; trends and possible basis. Springer-Verlag, New York.
257. Qadri, S. M., Y. Ueno, J. J. Burns, E. Almodovar, and N. Rabea. 1992. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone. Chemotherapy (Tokyo) 38: 99-106.
258. Qadri, S. M. H., Y. Ueno, and H. H. Frayha. 1991. In vitro activity of LY281389 and comparison with erythromycin and oral beta-lactams. Chemotherapy (Tokyo) 37:270-274.
259. Rhoden, D. L., G. A. Hancock, and J. M. Miller. 1993. Numerical approach to reference identification of Staphylococcus, Stomatococcus, and Micrococcus spp. J. Clin. Microbiol. 31:490-493.
260. Richardson, J. V., R. B. Karp, J. W. Kirklin, and W. E. Dismukes. 1978. Treatment of infective endocarditis: a 10-year comparative analysis. Circulation 58:589-597.
261. Rogers, H. J., and H. R. Perkins. 1960. 5-Fluorouracil and mucopeptide biosynthesis by Staphylococcus aureus. Biochem. J. 77:448-459.
262. Rolston, K. V. I., H. T. Nguyen, D. H. Ho, B. LeBlanc, and G. P. Bodey. 1992. In vitro activity of Ro23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents. Antimicrob. Agents Chemother. 36:879-882.
263. Rolston, K. V. I., H. Nguyen, and M. Messer. 1990. In vitro activity of LY264826, a new glycopeptide antibiotic against gram-positive bacteria isolated from patients with cancer. Antimicrob. Agents Chemother. 34:2137-2141.
264. Rosdahl, V. T., B. Gahrn-Hansen, J. K. Møller, and P. Kjaeldgaard. 1990. Phage-typing of coagulase-negative staphylococci. Acta Pathol. Microbiol. Immunol. Scand. 98:299-304.
265. Rosenbach, F. J. 1884. Mikro-organismen bei den Wund-Infections-Krankheiten des Menschen. J. F. Bergmann, Wiesbaden, Germany.
266. Ross, J., A. M. Farrell, E. A. Eady, J. H. Cove, and W. J. Cunliffe. 1989. Characterization and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J. Antimicrob. Chemother. 24: 851-862.
267. Rubin, J., W. A. Rogers, H. M. Taylor, E. D. Everett, B. F. Prowant, L. V. Fruto, and K. D. Nolph. 1980. Peritonitis during continuous ambulatory peritoneal dialysis. Ann. Intern. Med. 92:7-13.
268. Ryan-Poirier, K., and C. C. Patrick. 1993. Cervical adenitis caused by Staphylococcus epidermidis. J. Clin. Microbiol. 31:426-427.
269. Ryffel, C., F. H. Kayser, and B. Berger-Bächi. 1992. Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci. Antimicrob. Agents Chemother. 36:25-31.
270. Sanchez, M. L., R. P. Wenzel, and R. N. Jones. 1992. In vitro activity of decaplanin (M861410), a new glycopeptide antibiotic. Antimicrob. Agents Chemother. 36:873-875.
271. Schaberg, D. R., D. H. Culver, and R. P. Gaynes. 1991. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91(Suppl. 3B):72-75.
272. Schleifer, K. H., and U. Fischer. 1982. Description of a new species of the genus Staphylococcus: Staphylococcus carnosus. Int. J. Syst. Bacteriol. 32:153-156.
273. Schleifer, K. H., U. Geyer, R. Kilpper-Bälz, and L. A. Devriese. 1983. Elevation of Staphylococcus sciuri subsp. lentus (Kloos et al.) to species status: Staphylococcus lentus (Kloos et al.) comb. nov. Syst. Appl. Microbiol. 4:382-387.
274. Schleifer, K. H., R. Kilpper-Bälz, and L. A. Devriese. 1984. Staphylococcus arlettae sp. nov., S. equorum sp. nov., and 5. kloosii sp. nov.: three new coagulase-negative novobiocin-resistant species from animals. Syst. Appl. Microbiol. 5:501-509.
275. Schleifer, K. H., R. Kilpper-Bälz, U. Fischer, A. Faller, and J. Endl. 1982. Identification of "Micrococcus candidus" ATCC 14852 as a strain of Staphylococcus epidermidis and of "Micrococcus caseolyticus" ATCC 13548 and Micrococcus varians ATCC 29750 as members of a new species, Staphylococcus caseolyticus. Int. J. Syst. Bacteriol. 32:15-20.
276. Schleifer, K. H., and W. E. Kloos. 1975. Isolation and characterization of staphylococci from human skin. I. Amended description of Staphylococcus epidermidis and Staphylococcus saprophyticus and descriptions of three new species: Staphylococcus cohnii, Staphylococcus haemolyticus, and Staphylococcus xylosus. Int. J. Syst. Bacteriol. 25:50-61.
277. Schwalbe, R. S., W. J. Ritz, P. R. Verma, E. A. Barranco, and P. H. Gilligan. 1990. Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J. Infect. Dis. 161:45-51.
278. Schwalbe, R. S., J. T. Stapleton, and P. H. Gilligan. 1987. Emergence of vancomycin resistance in coagulase-negative staphylococci. N. Engl. J. Med. 316:927-931.
279. Scriver, S. R., B. M. Willey, D. E. Low, and A. E. Simor. 1992. Comparative in vitro activity of cefdinir (CI-983; FK-482) against staphylococci, gram-negative bacilli and respiratory tract pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 11:646-652.
280. Shuttleworth, R., and W. D. Colby. 1992. Staphylococcus lugdunensis endocarditis. J. Clin. Microbiol. 30:1948-1952.
281. Sidebottom, D. G., J. Freeman, R. Platt, M. F. Epstein, and D. A. Goldmann. 1988. Fifteen-year experience with blood-stream isolates of coagulase-negative staphylococci in neonatal intensive care. J. Clin. Microbiol. 26:713-718.
282. Singh, V. R., and I. Raad. 1990. Fatal Staphylococcus saprophyticus native valve endocarditis in an intravenous drug addict. J. Infect. Dis. 162:784-785.
283. Smith, I. M., P. D. Beals, K. R. Kingsbury, and N. F. Hasenclever. 1958. Observations on Staphylococcus albus septicemia in mice and men. Arch. Intern. Med. 102:375-388.
284. Smith, K. R., and C. G. Cobbs. 1992. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Eur. J. Clin. Microbiol. Infect. Dis. 11:55-58.
285. Sobel, J. D., and D. Kaye. 1985. Urinary tract infections, p. 426-452. In G. L. Mandell, R. G. Douglas, Jr., and J. E. Bennett (ed.), Principles and practice of infectious disease, 2nd ed. John Wiley & Sons, New York.
286. Stamey, T. A. 1980. Pathogenesis and treatment of urinary tract infections. Williams and Wilkins, Baltimore.
287. Stamm, W. E. 1988. Protocol for diagnosis of urinary tract infection: reconsidering the criterion for significant bacteriuria. Urology 32(Suppl.):6-10.
288. Stout, R. D., K. P. Ferguson, Y. Li, and D. W. Lambe, Jr. 1992. Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production. Infect. Immun. 60:922-927.
289. Stratton, C. W., M. S. Gelfand, J. L. Gerberding, and H. F. Chambers. 1990. Characterization of mechanisms of resistance to β-lactam antibiotics in methicillin-resistant strains of Staphylococcus saprophyticus. Antimicrob. Agents Chemother. 34: 1780-1782.
290. Sugarman, B., and E. J. Young. 1984. Infections associated with prosthetic devices. CRC Press, Boca Raton, Fla.
291. Suzuki, E., K. Hiramatsu, and T. Yokota. 1992. Survey of methicillin-resistant clinical strains of coagulase-negative staphylococci for mecA gene distribution. Antimicrob. Agents Chemother. 36:429-434.
292. Switalski, L. M., C. Ryden, K. Rubin, A. Ljungh, M. Höök, and T. Wadström. 1983. Binding of fibronectin to Staphylococcus strains. Infect. Immun. 42:628-633.
293. Takeda, S., G. B. Pier, Y. Kojima, M. Tojo, E. Muller, T. Tosteson, and D. A. Goldmann. 1991. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation 84:2539-2546.
294. Tanasupawat, S., Y. Hashimoto, T. Ezaki, M. Kozaki, and K. Komagata. 1992. Staphylococcus piscifermentans Sp. nov., from fermented fish in Thailand. Int. J. Syst. Bacteriol. 42:577-581.
295. Tesch, W., C. Ryffel, A. Strassle, F. H. Kayser, and B. Berger-Bächi. 1990. Evidence of a novel staphylococcal mecencoded element (mecR) controlling expression of penicillin-binding protein 2′. Antimicrob. Agents Chemother. 34:1703-1706.
296. Thomson, K. S., C. C. Sanders, and M. E. Hayden. 1991. In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises. Antimicrob. Agents Chemother. 35:2329-2334.
297. Thomson-Carter, F. M., P. E. Carter, and T. H. Pennington. 1989. Differentiation of staphylococcal species and strains by ribosomal RNA gene restriction patterns. J. Gen. Microbiol. 135:2093-2097.
298. Thomson-Carter, F. M., and T. H. Pennington. 1989. Characterization of coagulase-negative staphylococci by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot analyses. J. Clin. Microbiol. 27:2199-2203.
299. Timmerman, C. P., A. Fleer, J. M. Besnier, L. DeGraaf, F. Cremers, and J. Verhoef. 1991. Characterization of a proteinaceous adhesin of Staphylococcus epidermidis which mediates attachment to polystyrene. Infect. Immun. 59:4187-4192.
300. Tojo, M., N. Yamashita, D. A. Goldmann, and G. B. Pier. 1988. Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J. Infect. Dis. 157: 713-730.
301. Tollefson, D. F., D. F. Bandyk, H. W. Kaebnick, G. R. Seabrook, and J. B. Towne. 1987. Surface biofilm disruptionenhanced recovery of microorganisms from vascular prostheses. Arch. Surg. 122:38-43.
302. Ubukata, K., R. Nonoguchi, M. D. Song, M. Matsuhashi, and M. Konno. 1990. Homology of mecA gene in methicillin-resistant Staphylococcus haemolyticus and Staphylococcus simulans to that of Staphylococcus aureus. Antimicrob. Agents Chemother. 34:170-172.
303. Varaldo, P. E., R. Kilpper-Bälz, F. Biavasco, G. Satta, and K. H. Schleifer. 1988. Staphylococcus delphnii sp. nov., a coagulase-positive species isolated from dolphins. Int. J. Syst. Bacteriol. 38:436-439.
304. Veach, L. A., M. A. Pfaller, M. Barrett, F. P. Koontz, and R. P. Wenzel. 1990. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J. Clin. Microbiol. 28:2064-2068.
305. Wadström, T. 1989. Molecular aspects of bacterial adhesion, colonization, and development of infections associated with biomaterials. J. Invest. Surg. 2:353-360.
306. Wadström, T., P. Speziale, F. Rozgonyi, Å. Ljungh, I. Maxe, and C. Ryden. 1987. Interactions of coagulase-negative staphylococci with fibronectin and collagen as possible first step of tissue colonization in wounds and other tissue trauma. Zentralbl. Bakteriol. Mikrobiol. Hyg. Ser. A 16(Suppl.):83-91.
307. Wallmark, G. I., I. Anemark, and B. Telander. 1978. Staphylococcus saprophyticus: a frequent cause of urinary tract infections among female outpatients. J. Infect. Dis. 138:791-797.
308. Watanakunakorn, C. 1988. In vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin. J. Antimicrob. Chemother. 22:321-324.
309. Webster, J., R. Hubner, E. Cole, J. Bruce, T. Bannerman, D. Ballard, and W. Kloos. 1993. The Staphylococcus sciuri species group described by EcoRI fragments containing ribosomal RNA sequences, with recognition of Staphylococcus vitulus sp. nov., abstr. R-14, p. 295. Abstr. 93rd Gen. Meet. Am. Soc. Microbiol. 1993. American Society for Microbiology, Washington, D.C.
310. Wedrén, H. 1987. On chronic prostatitis with special studies of Staphylococcus epidermidis. Scand. J. Urol. Nephrol. Suppl. 123:1-36.
311. Welch, D. 1991. Applications of cellular fatty acid analysis. Clin. Microbiol. Rev. 4:422-438.
312. Wentworth, B. B. (ed.). 1987. Diagnostic procedures for bacterial infections, 7th ed. American Public Health Association, Washington, D.C.
313. Westblom, T. U., G. J. Gorse, T. W. Milligan, and A. H. Schindzielorz. 1990. Anaerobic endocarditis caused by Staphylococcus saccharolyticus. J. Clin. Microbiol. 28:2818-2819.
314. Whyte, W., W. Carson, and A. Hambraeus. 1989. Methods for calculating the efficiency of bacterial surface sampling techniques. J. Hosp. Infect. 13:33-41.
315. Widmer, A. F., M. Nettleman, K. Flint, and R. P. Wenzel. 1992. The clinical impact of culturing central venous catheters. Arch. Intern. Med. 152:1299-1302.
316. Wilcox, M. H., R. G. Finch, D. G. E. Smith, P. Williams, and S. P. Denyer. 1991. Effects of carbon dioxide and sub-lethal levels of antibiotics on adherence of coagulase-negative staphylococci to polystyrene and silicone rubber. J. Antimicrob. Chemother. 27:577-587.
317. Wilcox, M. H., M. Hussein, M. K. Faulkner, P. J. White, and R. C. Spencer. 1991. Slime production and adherence by coagulase-negative staphylococci. J. Hosp. Infect. 18:327-331.
318. Wilson, T. S., and R. D. Stuart. 1965. Staphylococcus albus in wound infection and in septicemia. Can. Med. Assoc. J. 93:8-16.
319. Wilton, J., K. Jung, I. Vedin, B. Aronsson, and J. I. Flock. 1992. Comparative evaluation of a new molecular method for typing Staphylococcus epidermidis. Eur. J. Clin. Microbiol. Infect. Dis. 11:515-521.
320. Wolfson, J. S., and D. C. Hooper. 1989. Fluoroquinolone antimicrobial agents. Clin. Microbiol. Rev. 2:378-424.
321. Wood, C. A., D. L. Sewell, and L. J. Strausbaugh. 1989. Vertebral osteomyelitis and native valve endocarditis caused by Staphylococcus warnen. Diagn. Microbiol. Infect. Dis. 12:261-263.
322. Woods, G. L., G. S. Hall, I. Rutherford, K. J. Pratt, and C. C. Knapp. 1986. Detection of methicillin-resistant Staphylococcus epidermidis. J. Clin. Microbiol. 24:349-352.
323. Zimmerman, R. J., and W. E. Kloos. 1976. Comparative zone electrophoresis of esterases of Staphylococcus species isolated from mammalian skin. Can. J. Microbiol. 22:771-779.